地西他滨通过靶向DNA甲基转移酶3A(DNMT3A)和DNA甲基转移酶3B(DNMT3B)改善丝裂霉素诱导的视网膜光感受器细胞损伤。
Decitabine improves MMS-induced retinal photoreceptor cell damage by targeting DNMT3A and DNMT3B.
作者信息
Ji Yanli, Zhao Meng, Qiao Xiaomeng, Peng Guang-Hua
机构信息
Laboratory of Visual Cell Differentiation and Regulation, Basic Medical College, Zhengzhou University, Zhengzhou, China.
Department of Pathophysiology, Basic Medical College, Zhengzhou University, Zhengzhou, China.
出版信息
Front Mol Neurosci. 2023 Jan 10;15:1057365. doi: 10.3389/fnmol.2022.1057365. eCollection 2022.
INTRODUCTION
Retinitis pigmentosa (RP) is a group of neurodegenerative retinopathies causing blindness due to progressive and irreversible photoreceptor cell death. The alkylating agent methyl methanesulfonate (MMS) can induce selective photoreceptor cell death, which is used to establish RP animal models. MMS induces DNA base damage by adding alkyl groups to DNA, and epigenetic modifications influence DNA damage response. Here, we aimed to explore the relationship between DNA methylation and DNA damage response in dying photoreceptors of RP.
METHODS
The mouse RP model was established by a single intraperitoneal injection of MMS. The retinal structure and function were assessed by H&E, OCT, TUNEL, and ERG at several time points. The expression of DNA methylation regulators was assessed by qPCR and Western blot. DNMT inhibitor 5-aza-dC was applied to inhibit the activity of DNA methyltransferases and improve the retinal photoreceptor damage.
RESULTS
The outer nuclear layer (ONL) and IS/OS layer were significantly thinner and the retinal function was impaired after MMS treatment. The cell death was mainly located in the ONL. The retinal damage induced by MMS was accompanied by hyperexpression of DNMT3A/3B. The application of DNMT inhibitor 5-aza-dC could suppress the expression level of DNMT3A/3B, resulting in the remission of MMS-induced photoreceptor cell damage. The ONL and IS/OS layers were thicker than that of the control group, and the retinal function was partially restored. This protective effect of 5-aza-dC was associated with the down-regulated expression of DNMT3A/3B.
CONCLUSION
These findings identified a functional role of DNMT3A/3B in MMS-induced photoreceptor cell damage and provided novel evidence to support DNMTs as potential therapeutic targets in retinal degenerative diseases.Graphical Abstract.
引言
视网膜色素变性(RP)是一组神经退行性视网膜病变,由于光感受器细胞进行性和不可逆性死亡而导致失明。烷化剂甲磺酸甲酯(MMS)可诱导选择性光感受器细胞死亡,用于建立RP动物模型。MMS通过向DNA添加烷基来诱导DNA碱基损伤,表观遗传修饰影响DNA损伤反应。在此,我们旨在探讨RP垂死光感受器中DNA甲基化与DNA损伤反应之间的关系。
方法
通过单次腹腔注射MMS建立小鼠RP模型。在多个时间点通过苏木精-伊红染色(H&E)、光学相干断层扫描(OCT)、末端脱氧核苷酸转移酶介导的缺口末端标记(TUNEL)和视网膜电图(ERG)评估视网膜结构和功能。通过定量聚合酶链反应(qPCR)和蛋白质免疫印迹法评估DNA甲基化调节因子的表达。应用DNA甲基转移酶抑制剂5-氮杂胞苷(5-aza-dC)抑制DNA甲基转移酶的活性并改善视网膜光感受器损伤。
结果
MMS处理后,外核层(ONL)和内节/外节(IS/OS)层明显变薄,视网膜功能受损。细胞死亡主要位于ONL。MMS诱导的视网膜损伤伴有DNA甲基转移酶3A/3B(DNMT3A/3B)的过表达。应用DNMT抑制剂5-aza-dC可抑制DNMT3A/3B的表达水平,导致MMS诱导的光感受器细胞损伤得到缓解。ONL和IS/OS层比对照组更厚,视网膜功能部分恢复。5-aza-dC的这种保护作用与DNMT3A/3B表达下调有关。
结论
这些发现确定了DNMT3A/3B在MMS诱导的光感受器细胞损伤中的功能作用,并提供了新的证据支持将DNA甲基转移酶作为视网膜退行性疾病的潜在治疗靶点。图形摘要。